These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4808251)

  • 41. Internal indicators for the management and prognosis of patients in a methadone maintenance program (internal states self-report scale).
    Fisch A; Patch VD; Greenfield A; Raynes AE; McKenna G; Levine M
    Proc Natl Conf Methadone Treat; 1973; 1():433-9. PubMed ID: 4808181
    [No Abstract]   [Full Text] [Related]  

  • 42. [Methadone used in the treatment of opioid dependence].
    Waal H; Blix O; Krook A; Olsen H
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):237-41. PubMed ID: 10081357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of level of anxiety, depression and hostility with methadone plasma concentration in opioid-dependent patients receiving methadone on a maintenance dosage schedule.
    Blake DA; Distasio C
    Proc Natl Conf Methadone Treat; 1973; 2():1308-16. PubMed ID: 4808284
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nursing care in ambulatory methadone programs. A comparative literature study between The Netherlands and The United States].
    Loth CA; van de Wijngaart GF
    Verpleegkunde; 1997 Aug; 12(3):150-9. PubMed ID: 9385233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experiences in dispensing methadone in a factory.
    Hersch RG; Schooff KG
    Proc Natl Conf Methadone Treat; 1973; 1():652-7. PubMed ID: 4808216
    [No Abstract]   [Full Text] [Related]  

  • 47. Statement and resolution regarding methadone maintenance treatment. Subcommittee on Drug Abuse, Committee on Public Health of the New York Academy of Medicine.
    Bull N Y Acad Med; 1982 Sep; 58(6):579-84. PubMed ID: 6959682
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytogenetic follow-up of patients in a methadone maintenance program.
    Falek A; McFadden IJ
    Proc Natl Conf Methadone Treat; 1973; 1():695-705. PubMed ID: 4808222
    [No Abstract]   [Full Text] [Related]  

  • 49. [Methadone maintenance treatment of heroin addiction].
    Trimbos CJ
    Ned Tijdschr Geneeskd; 1971 Feb; 115(7):261-6. PubMed ID: 4950468
    [No Abstract]   [Full Text] [Related]  

  • 50. Methadone maintenance and the national perspective.
    Jaffe JH
    Proc Natl Conf Methadone Treat; 1973; 2():1414-21. PubMed ID: 4808295
    [No Abstract]   [Full Text] [Related]  

  • 51. One model for a methadone maintenance program to serve a community of catchment area size up to 250,000 people.
    Jackman JM
    Proc Natl Conf Methadone Treat; 1973; 1():179-81. PubMed ID: 4808147
    [No Abstract]   [Full Text] [Related]  

  • 52. Renovation and expansion of health facilities: off-site services effect economy.
    Rosenfeld N
    Hospitals; 1974 Feb; 48(3):93-6. PubMed ID: 4811539
    [No Abstract]   [Full Text] [Related]  

  • 53. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why is methadone maintenance successful?
    Bourne PG; Slade J
    Proc Natl Conf Methadone Treat; 1973; 2():1086-92. PubMed ID: 4808253
    [No Abstract]   [Full Text] [Related]  

  • 55. Refining cost benefit estimates of methadone programs.
    Backhaut B
    Proc Natl Conf Methadone Treat; 1973; 2():1227-30. PubMed ID: 4808272
    [No Abstract]   [Full Text] [Related]  

  • 56. [Methadone maintenance: adoption of a new harm reduction approach in Hungary].
    Szabó L; Polgár P; Gerevich J
    Orv Hetil; 2005 Aug; 146(32):1685-91. PubMed ID: 16149246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Parrino MW
    J Subst Abuse Treat; 2003 Sep; 25(2):71-3. PubMed ID: 14629988
    [No Abstract]   [Full Text] [Related]  

  • 58. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Coppola JJ
    J Subst Abuse Treat; 2003 Sep; 25(2):65-6. PubMed ID: 14629985
    [No Abstract]   [Full Text] [Related]  

  • 59. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Heaps MM; Lurigio AJ
    J Subst Abuse Treat; 2003 Sep; 25(2):69-70. PubMed ID: 14629987
    [No Abstract]   [Full Text] [Related]  

  • 60. Individually focused treatment of methadone maintenance patients in contrasting settings.
    Eaton CR; Pascarelli EF
    Proc Natl Conf Methadone Treat; 1973; 2():1207-12. PubMed ID: 4808269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.